Mycobacterium tuberculosis Rv3628 is an effective adjuvant via activation of dendritic cells for cancer immunotherapy

Autor: Wu, Juan, Yang, Heng, Xu, Jin-chuan, Hu, Zhidong, Gu, Wen-fei, Chen, Zhen-yan, Xia, Jing-xian, Lowrie, Douglas B., Lu, Shui-Hua, Fan, Xiao-Yong
Zdroj: In Molecular Therapy - Oncolytics 17 December 2021 23:288-302
Databáze: ScienceDirect